NEUVIVO
Live / Allowed — Published for opposition (as of 15 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99706797
- Mark type
- Design + words
- Filed
- 17 Mar 2026
- Published for opposition
- 15 Sept 2026
- Attorney of record
- Christopher M. Turk
Goods and services
- Class 042 — Scientific and technological services: Providing medical research information in the field of pharmaceuticals; development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research services; research and development in the pharmaceutical and biotechnology fields; clinical laboratory services, namely, laboratory research services for assessment of pharmaceutical efficacy
Owner
- Neuvivo, Inc., Palo Alto, CA, US
- Neuvivo, Inc., Palo Alto, CA, US
Prosecution history
- 15 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2026 — PUBLISHED FOR OPPOSITION
- 09 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Aug 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Aug 2026 — EXAMINER'S AMENDMENT ENTERED
- 05 Aug 2026 — EXAMINERS AMENDMENT E-MAILED
- 05 Aug 2026 — EXAMINERS AMENDMENT -WRITTEN
- 28 Jul 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Jul 2026 — NON-FINAL ACTION E-MAILED
- 28 Jul 2026 — NON-FINAL ACTION WRITTEN
- 20 Jul 2026 — ASSIGNED TO EXAMINER
- 17 Jul 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 17 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Mar 2026 — APPLICATION FILING RECEIPT MAILED